Filgrastim


( Last Updated : August 12, 2015)
Generic Name:
Filgrastim
Project Status:
Complete
Therapeutic Area:
Neutropenia
Manufacturer:
Apotex Inc.
Call for patient/clinician input open:
Brand Name:
Grastofil
Project Line:
Reimbursement Review
Project Number:
SE0446-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Biosimilar:
Yes
Submission Type:
Initial
Indications:
Prevention or treatment of neutropenia in various indications
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: